Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0031248 | protein acetyltransferase complex | 3 | 2 |
GO:0031414 | N-terminal protein acetyltransferase complex | 4 | 2 |
GO:0031416 | NatB complex | 5 | 2 |
GO:0032991 | protein-containing complex | 1 | 2 |
GO:0140535 | intracellular protein-containing complex | 2 | 2 |
GO:1902493 | acetyltransferase complex | 4 | 2 |
GO:1902494 | catalytic complex | 2 | 2 |
GO:1990234 | transferase complex | 3 | 2 |
Related structures:
AlphaFold database: Q4QA94
Term | Name | Level | Count |
---|---|---|---|
GO:0006473 | protein acetylation | 6 | 2 |
GO:0006474 | N-terminal protein amino acid acetylation | 5 | 2 |
GO:0006807 | nitrogen compound metabolic process | 2 | 2 |
GO:0008152 | metabolic process | 1 | 2 |
GO:0017196 | N-terminal peptidyl-methionine acetylation | 6 | 2 |
GO:0018193 | peptidyl-amino acid modification | 5 | 2 |
GO:0018206 | peptidyl-methionine modification | 6 | 2 |
GO:0019538 | protein metabolic process | 3 | 2 |
GO:0031365 | N-terminal protein amino acid modification | 5 | 2 |
GO:0036211 | protein modification process | 4 | 2 |
GO:0043170 | macromolecule metabolic process | 3 | 2 |
GO:0043412 | macromolecule modification | 4 | 2 |
GO:0043543 | protein acylation | 5 | 2 |
GO:0044238 | primary metabolic process | 2 | 2 |
GO:0051604 | protein maturation | 4 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 2 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 11 |
GO:0004596 | peptide alpha-N-acetyltransferase activity | 8 | 2 |
GO:0008080 | N-acetyltransferase activity | 6 | 2 |
GO:0016407 | acetyltransferase activity | 5 | 11 |
GO:0016410 | N-acyltransferase activity | 5 | 2 |
GO:0016740 | transferase activity | 2 | 11 |
GO:0016746 | acyltransferase activity | 3 | 11 |
GO:0016747 | acyltransferase activity, transferring groups other than amino-acyl groups | 4 | 11 |
GO:0034212 | peptide N-acetyltransferase activity | 7 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 124 | 126 | PF00675 | 0.278 |
CLV_NRD_NRD_1 | 153 | 155 | PF00675 | 0.382 |
CLV_NRD_NRD_1 | 19 | 21 | PF00675 | 0.429 |
CLV_NRD_NRD_1 | 202 | 204 | PF00675 | 0.373 |
CLV_NRD_NRD_1 | 207 | 209 | PF00675 | 0.416 |
CLV_NRD_NRD_1 | 39 | 41 | PF00675 | 0.494 |
CLV_NRD_NRD_1 | 46 | 48 | PF00675 | 0.335 |
CLV_PCSK_KEX2_1 | 124 | 126 | PF00082 | 0.278 |
CLV_PCSK_KEX2_1 | 202 | 204 | PF00082 | 0.496 |
CLV_PCSK_KEX2_1 | 207 | 209 | PF00082 | 0.507 |
CLV_PCSK_KEX2_1 | 38 | 40 | PF00082 | 0.556 |
CLV_PCSK_KEX2_1 | 46 | 48 | PF00082 | 0.327 |
CLV_PCSK_PC7_1 | 198 | 204 | PF00082 | 0.487 |
CLV_PCSK_SKI1_1 | 125 | 129 | PF00082 | 0.402 |
CLV_PCSK_SKI1_1 | 173 | 177 | PF00082 | 0.330 |
CLV_PCSK_SKI1_1 | 198 | 202 | PF00082 | 0.482 |
CLV_PCSK_SKI1_1 | 217 | 221 | PF00082 | 0.446 |
CLV_PCSK_SKI1_1 | 40 | 44 | PF00082 | 0.571 |
CLV_PCSK_SKI1_1 | 46 | 50 | PF00082 | 0.400 |
DOC_CYCLIN_yCln2_LP_2 | 215 | 221 | PF00134 | 0.405 |
DOC_MAPK_gen_1 | 18 | 28 | PF00069 | 0.527 |
DOC_MAPK_gen_1 | 205 | 215 | PF00069 | 0.414 |
DOC_MAPK_RevD_3 | 6 | 21 | PF00069 | 0.413 |
DOC_USP7_MATH_1 | 137 | 141 | PF00917 | 0.405 |
DOC_USP7_MATH_1 | 187 | 191 | PF00917 | 0.498 |
DOC_USP7_UBL2_3 | 185 | 189 | PF12436 | 0.477 |
DOC_USP7_UBL2_3 | 205 | 209 | PF12436 | 0.376 |
DOC_USP7_UBL2_3 | 21 | 25 | PF12436 | 0.436 |
LIG_14-3-3_CanoR_1 | 13 | 19 | PF00244 | 0.426 |
LIG_14-3-3_CanoR_1 | 207 | 213 | PF00244 | 0.406 |
LIG_14-3-3_CanoR_1 | 38 | 43 | PF00244 | 0.661 |
LIG_14-3-3_CanoR_1 | 46 | 51 | PF00244 | 0.421 |
LIG_AP2alpha_1 | 148 | 152 | PF02296 | 0.278 |
LIG_FHA_1 | 129 | 135 | PF00498 | 0.294 |
LIG_FHA_1 | 89 | 95 | PF00498 | 0.391 |
LIG_FHA_2 | 47 | 53 | PF00498 | 0.395 |
LIG_LIR_Gen_1 | 12 | 19 | PF02991 | 0.523 |
LIG_LIR_Gen_1 | 162 | 172 | PF02991 | 0.317 |
LIG_LIR_Gen_1 | 53 | 64 | PF02991 | 0.409 |
LIG_LIR_Gen_1 | 82 | 90 | PF02991 | 0.361 |
LIG_LIR_Nem_3 | 12 | 17 | PF02991 | 0.522 |
LIG_LIR_Nem_3 | 122 | 126 | PF02991 | 0.278 |
LIG_LIR_Nem_3 | 162 | 167 | PF02991 | 0.272 |
LIG_LIR_Nem_3 | 53 | 59 | PF02991 | 0.436 |
LIG_LIR_Nem_3 | 70 | 76 | PF02991 | 0.255 |
LIG_LIR_Nem_3 | 78 | 83 | PF02991 | 0.355 |
LIG_PDZ_Class_3 | 222 | 227 | PF00595 | 0.542 |
LIG_PDZ_Wminus1_1 | 225 | 227 | PF00595 | 0.578 |
LIG_Pex14_2 | 10 | 14 | PF04695 | 0.417 |
LIG_Pex14_2 | 148 | 152 | PF04695 | 0.278 |
LIG_PTB_Apo_2 | 142 | 149 | PF02174 | 0.267 |
LIG_SH2_CRK | 164 | 168 | PF00017 | 0.278 |
LIG_SH2_CRK | 172 | 176 | PF00017 | 0.317 |
LIG_SH2_CRK | 83 | 87 | PF00017 | 0.259 |
LIG_SH2_STAT5 | 147 | 150 | PF00017 | 0.293 |
LIG_SH2_STAT5 | 169 | 172 | PF00017 | 0.297 |
LIG_SH2_STAT5 | 76 | 79 | PF00017 | 0.355 |
LIG_SH2_STAT5 | 98 | 101 | PF00017 | 0.333 |
LIG_SH3_2 | 184 | 189 | PF14604 | 0.577 |
LIG_SH3_3 | 181 | 187 | PF00018 | 0.574 |
LIG_SH3_3 | 215 | 221 | PF00018 | 0.388 |
LIG_SH3_3 | 3 | 9 | PF00018 | 0.421 |
LIG_SUMO_SIM_par_1 | 130 | 135 | PF11976 | 0.375 |
LIG_TYR_ITIM | 170 | 175 | PF00017 | 0.323 |
MOD_CK1_1 | 115 | 121 | PF00069 | 0.278 |
MOD_CK1_1 | 12 | 18 | PF00069 | 0.507 |
MOD_GlcNHglycan | 114 | 117 | PF01048 | 0.279 |
MOD_GSK3_1 | 115 | 122 | PF00069 | 0.278 |
MOD_GSK3_1 | 46 | 53 | PF00069 | 0.444 |
MOD_GSK3_1 | 64 | 71 | PF00069 | 0.315 |
MOD_N-GLC_1 | 68 | 73 | PF02516 | 0.485 |
MOD_NEK2_1 | 128 | 133 | PF00069 | 0.302 |
MOD_NEK2_1 | 50 | 55 | PF00069 | 0.430 |
MOD_NEK2_1 | 64 | 69 | PF00069 | 0.278 |
MOD_NEK2_1 | 96 | 101 | PF00069 | 0.351 |
MOD_NEK2_2 | 68 | 73 | PF00069 | 0.438 |
MOD_PK_1 | 208 | 214 | PF00069 | 0.468 |
MOD_PKA_1 | 207 | 213 | PF00069 | 0.462 |
MOD_PKA_1 | 38 | 44 | PF00069 | 0.392 |
MOD_PKA_1 | 46 | 52 | PF00069 | 0.376 |
MOD_PKA_2 | 12 | 18 | PF00069 | 0.422 |
MOD_PKA_2 | 153 | 159 | PF00069 | 0.301 |
MOD_PKA_2 | 207 | 213 | PF00069 | 0.463 |
MOD_PKA_2 | 38 | 44 | PF00069 | 0.652 |
MOD_PKA_2 | 46 | 52 | PF00069 | 0.459 |
MOD_PKB_1 | 38 | 46 | PF00069 | 0.446 |
MOD_Plk_1 | 68 | 74 | PF00069 | 0.480 |
MOD_Plk_4 | 1 | 7 | PF00069 | 0.463 |
MOD_Plk_4 | 128 | 134 | PF00069 | 0.360 |
MOD_Plk_4 | 208 | 214 | PF00069 | 0.412 |
MOD_Plk_4 | 68 | 74 | PF00069 | 0.402 |
MOD_SUMO_for_1 | 219 | 222 | PF00179 | 0.420 |
TRG_ENDOCYTIC_2 | 164 | 167 | PF00928 | 0.278 |
TRG_ENDOCYTIC_2 | 172 | 175 | PF00928 | 0.310 |
TRG_ENDOCYTIC_2 | 45 | 48 | PF00928 | 0.412 |
TRG_ENDOCYTIC_2 | 83 | 86 | PF00928 | 0.326 |
TRG_ER_diArg_1 | 123 | 125 | PF00400 | 0.278 |
TRG_ER_diArg_1 | 17 | 20 | PF00400 | 0.530 |
TRG_ER_diArg_1 | 201 | 203 | PF00400 | 0.432 |
TRG_ER_diArg_1 | 38 | 40 | PF00400 | 0.563 |
TRG_ER_diArg_1 | 45 | 47 | PF00400 | 0.382 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I212 | Leptomonas seymouri | 91% | 100% |
A0A0S4JB69 | Bodo saltans | 27% | 80% |
A0A0S4KNL4 | Bodo saltans | 64% | 100% |
A0A1X0NYV1 | Trypanosomatidae | 77% | 100% |
A0A3Q8ID89 | Leishmania donovani | 95% | 100% |
A0A3R7M1B7 | Trypanosoma rangeli | 29% | 90% |
A0A422N4M9 | Trypanosoma rangeli | 77% | 100% |
A4HDU9 | Leishmania braziliensis | 91% | 100% |
A4I144 | Leishmania infantum | 95% | 100% |
C9ZKU0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 74% | 100% |
D0A6U8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 28% | 85% |
E9AXY0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 86% | 95% |
O61219 | Caenorhabditis elegans | 31% | 100% |
O74457 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 45% | 100% |
P36416 | Dictyostelium discoideum | 29% | 100% |
P41227 | Homo sapiens | 29% | 97% |
P61599 | Homo sapiens | 53% | 100% |
P61600 | Mus musculus | 53% | 100% |
Q05885 | Leishmania donovani | 98% | 100% |
Q06504 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 40% | 100% |
Q2KI14 | Bos taurus | 29% | 97% |
Q2PFM2 | Macaca fascicularis | 53% | 100% |
Q3UX61 | Mus musculus | 29% | 100% |
Q4V8K3 | Rattus norvegicus | 29% | 92% |
Q58ED9 | Danio rerio | 52% | 100% |
Q6P632 | Xenopus tropicalis | 51% | 100% |
Q7ZXR3 | Xenopus laevis | 52% | 100% |
Q8LGI8 | Arabidopsis thaliana | 54% | 100% |
Q8SSN5 | Dictyostelium discoideum | 51% | 100% |
Q9BSU3 | Homo sapiens | 28% | 99% |
Q9FKI4 | Arabidopsis thaliana | 33% | 100% |
Q9QY36 | Mus musculus | 29% | 97% |
Q9UTI3 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 28% | 100% |
V5BDZ0 | Trypanosoma cruzi | 28% | 88% |